CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - FINAL REPORT OF A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS

被引：232
|
作者：
BRAMWELL, VHC
MOURIDSEN, HT
SANTORO, A
BLACKLEDGE, G
SOMERS, R
VERWEY, J
DOMBERNOWSKY, P
ONSRUD, M
THOMAS, D
SYLVESTER, R
VANOOSTEROM, A
机构：
[1] CHRISTIE HOSP & HOLT RADIUM INST,MANCHESTER M20 9BX,LANCS,ENGLAND
[2] FINSEN INST,DK-2100 COPENHAGEN O,DENMARK
[3] INST NAZ DEI TUMORI,MILAN,ITALY
[4] QUEEN ELIZABETH HOSP,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND
[5] ANTONI VANLEEUWENHOEK HOSP,AMSTERDAM,NETHERLANDS
[6] ROTTERDAM RADIOTHERAPEUT INST,ROTTERDAM,NETHERLANDS
[7] HERLEV HOSP,DK-2730 HERLEV,DENMARK
[8] DER NORSKE RADIUM HOSP,OSLO,NORWAY
[9] EORTC DATA CTR,BRUSSELS,BELGIUM
[10] AKAD ZIEKENHUIS,LEIDEN,NETHERLANDS
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1987年 / 23卷 / 03期
关键词：
D O I：
10.1016/0277-5379(87)90075-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：311 / 321
页数：11
相关论文
共 50 条
  • [1] CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS
    BRAMWELL, VHC
    MOURIDSEN, HT
    SANTORO, A
    BLACKLEDGE, G
    SOMERS, R
    VERWEIJ, J
    DOMBERNOWSKY, P
    ONSRUD, M
    THOMAS, D
    SYLVESTER, R
    VANOOSTEROM, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 31 : S180 - S184
  • [2] CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - PRELIMINARY-REPORT OF A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS
    BRAMWELL, VHC
    MOURIDSEN, HT
    SANTORO, A
    BLACKLEDGE, G
    SOMERS, R
    THOMAS, D
    SYLVESTER, R
    VANOOSTEROM, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 : S13 - S16
  • [3] PHASE-II TRIAL OF METHYLENE DIMETHANE SULFONATE (MDMS) IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT
    STEWARD, WP
    MOURIDSEN, HT
    KERBRAT, P
    SOMERS, R
    VERWEIJ, J
    VANOOSTEROM, AT
    BLACKLEDGE, G
    HAVSTEEN, H
    THOMAS, D
    SYLVESTER, R
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (08): : 1251 - 1253
  • [4] A PHASE-II STUDY OF IFOSFAMIDE MESNA WITH DOXORUBICIN FOR ADULT SOFT-TISSUE SARCOMA
    CANTWELL, BMJ
    CARMICHAEL, J
    GHANI, S
    HARRIS, AL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 21 (01) : 49 - 52
  • [5] PHASE-II STUDY WITH DOCETAXEL (TAXOTERE(R)) IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT
    VANHOESEL, OGCM
    VERWEIJ, J
    CATIMEL, G
    CLAVEL, M
    KERBRAT, P
    VANOOSTEROM, AT
    KERGER, J
    TURSZ, T
    VANGLABBEKE, M
    VANPOTTELSBERGHE, C
    LEBAIL, N
    MOURIDSEN, H
    ANNALS OF ONCOLOGY, 1994, 5 (06) : 539 - 542
  • [6] PHASE-II STUDY OF FOTEMUSTINE IN ADVANCED SOFT-TISSUE SARCOMAS - A TRIAL OF THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP
    KERBRAT, P
    SOMERS, R
    VERWEIJ, J
    CROWTHER, D
    TURSZ, T
    SANTORO, A
    STEWARD, WP
    LENTZ, MA
    VANGLABBEKE, M
    MOURIDSEN, HT
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) : 143 - 144
  • [7] ADRIAMYCIN VERSUS EPIRUBICIN IN ADVANCED SOFT-TISSUE SARCOMAS - A RANDOMIZED PHASE-II PHASE-III STUDY OF THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP
    MOURIDSEN, HT
    BASTHOLT, L
    SOMERS, R
    SANTORO, A
    BRAMWELL, V
    MULDER, JH
    VANOOSTEROM, AT
    BUESA, J
    PINEDO, HM
    THOMAS, D
    SYLVESTER, R
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (10): : 1477 - 1483
  • [8] EPIRUBICIN AND IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMA - A PHASE-II STUDY
    CHEVALLIER, B
    LEYVRAZ, S
    OLIVIER, JP
    FARGEOT, P
    FACCHINI, T
    VAN, MLV
    CANCER INVESTIGATION, 1993, 11 (02) : 135 - 139
  • [9] PHASE-II TRIAL OF CARBOPLATIN IN SOFT-TISSUE SARCOMA
    GOLDSTEIN, D
    CHEUVART, B
    TRUMP, DL
    SHIRAKI, M
    COMIS, RL
    TORMEY, DC
    HARRIS, JE
    BORDEN, EC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (05): : 420 - 423
  • [10] CARMINOMYCIN VS ADRIAMYCIN IN ADVANCED SOFT-TISSUE SARCOMAS - AN EORTC RANDOMIZED PHASE-II STUDY
    BRAMWELL, VHC
    MOURIDSEN, HT
    MULDER, JH
    SOMERS, R
    VANOOSTEROM, AT
    SANTORO, A
    THOMAS, D
    SYLVESTER, R
    MARKHAM, D
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (08): : 1097 - 1104
12345